Alphatec Holdings Inc  

(Public, NASDAQ:ATEC)   Watch this stock  
Find more results for Alphatec Holdings Inc
1.30
-0.09 (-6.47%)
Nov 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.27 - 1.42
52 week 1.16 - 2.53
Open 1.40
Vol / Avg. 280,740.00/150,251.00
Mkt cap 133.41M
P/E     -
Div/yield     -
EPS -0.75
Shares 98.19M
Beta 1.80
Inst. own 59%
Dec 11, 2014
Alphatec Holdings Inc at Oppenheimer Healthcare Conference - 2:10PM EST - Add to calendar
Dec 3, 2014
Alphatec Holdings Inc at Piper Jaffray Healthcare Conference - 3:00PM EST - Add to calendar
Nov 20, 2014
Alphatec Holdings Inc at Canaccord Genuity Medical Technologies & Diagnostics Forum
Nov 18, 2014
Alphatec Holdings Inc at Stifel Healthcare Conference
Oct 30, 2014
Q3 2014 Alphatec Holdings Inc Earnings Call
Oct 30, 2014
Q3 2014 Alphatec Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -5.96% -40.16%
Operating margin 3.40% -35.87%
EBITD margin - 9.81%
Return on average assets -3.42% -21.99%
Return on average equity -7.69% -39.39%
Employees 500 -
CDP Score - -

Address

5818 El Camino Real
CARLSBAD, CA 92008
United States - Map
+1-760-4319286 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alphatec Holdings, Inc. (Alphatec) is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. The Company has product portfolio and pipelines that addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a variety of spinal disorders and procedures. The Company's principal product offerings are focused on the worldwide market for orthopedic spinal disorder solutions. The Company's principal product offering includes a variety of spinal implant products and systems consisted of components, such as spine screws and rods, spinal spacers, plates, and various biologics offerings. In addition, outside of the United States, the Company sells solutions for treating vertebral compression fractures and spinal stenosis.

Officers and directors

James M. Corbett President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Michael O'Neill Chief Financial Officer, Vice President, Treasurer
Age: 54
Bio & Compensation  - Reuters
Mitsuo Asai President of Alphatec Pacific, Inc.
Age: 59
Bio & Compensation  - Reuters
Michael Plunkett Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Ebun S. Garner Esq. Senior Vice President, General Counsel, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Leslie H. Cross Non-Executive Independent Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Mortimer Berkowitz III Director
Age: 60
Bio & Compensation  - Reuters
John H. Foster Director
Age: 71
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Rohit M. Desai Independent Director
Age: 75
Bio & Compensation  - Reuters
James R. Glynn Independent Director
Age: 67
Bio & Compensation  - Reuters